ConductScience.org, home

Gene · 4860

PNP: purine nucleoside phosphorylase

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. PNP: purine nucleoside phosphorylase. Genes, record 4860. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/4860

On this page

Gene

Symbol
PNP
HGNC
Name
purine nucleoside phosphorylase
HGNC
NCBI Gene ID
4860
NCBI Gene
HGNC ID
HGNC:7892
HGNC
Ensembl
ENSG00000198805
NCBI Gene
Aliases
NP, PRO1837, PUNP
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P00491Purine nucleoside phosphorylase28941Ensembl, GeneID, HGNC

Source UniProt

Patents53

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026067851 A2026-04-21363P00491Espacenet
JP 2026004568 A2026-01-1460465P00491Espacenet
EP 4650780 A22025-11-197882P00491Espacenet
JP 2025147176 A2025-10-0610591P00491Espacenet
JP 2025529142 A2025-09-047394P00491Espacenet
US 12371689 B22025-07-297394P00491Espacenet
JP 2025517970 A2025-06-127882P00491Espacenet
JP 2025032204 A2025-03-1133795P00491Espacenet
JP 2025028160 A2025-02-2810591P00491Espacenet
KR 1020250010750 A2025-01-2110591P00491Espacenet

1 to 10 of 53

See all 53 patents

Drugs3

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
FORODESINECHEMBL218291Purine nucleoside phosphorylase inhibitorINHIBITORChEMBL
FORODESINE HYDROCHLORIDECHEMBL550755Purine nucleoside phosphorylase inhibitorINHIBITORChEMBL
ULODESINECHEMBL269864Purine nucleoside phosphorylase inhibitorINHIBITORChEMBL

Trials18

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT01776411FORODESINEPHASE1/PHASE2ClinicalTrials.gov
NCT01407874ULODESINEPHASE2ClinicalTrials.gov
NCT01265264ULODESINEPHASE2ClinicalTrials.gov
NCT01129648ULODESINEPHASE2ClinicalTrials.gov
NCT00985127ULODESINEPHASE2ClinicalTrials.gov
NCT00823355FORODESINEPHASE1ClinicalTrials.gov
NCT00742495FORODESINEPHASE1/PHASE2ClinicalTrials.gov
NCT00646165FORODESINEPHASE1ClinicalTrials.gov
NCT00640523FORODESINEPHASE2ClinicalTrials.gov
NCT00501735FORODESINEPHASE2ClinicalTrials.gov

1 to 10 of 18

See all 18 trials

NIH grants1,683

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitlePNP papersNewest fiscal year
P30CA016672Cancer Center Support Grant72025
P30CA013330Cancer Center Support Grant52025
P30ES009089Center for Environmental Health in Northern Manhattan52025
R01GM121441Earth abundant catalysts as an enabling tool for organic synthesis52025
ZIAAI001222Characterization of the cellular and molecular bases of inborn errors of immunity52025
K12GM102779Bronx-Einstein Training in Teaching and Research (BETTR), an IRACDA program42025
P30CA016058Cancer Center Support Grant42025
P41EB017183Center for Advanced Imaging Innovation and Research (CAI2R)42025
R13AI094943Annual Primary Immune Deficiency Treatment Consortium (PIDTC) Workshop and Education Day42025
R35GM145213Protein dynamics from femtoseconds to milliseconds as crafted by natural and laboratory evolution: towards enzyme design42025

1 to 10 of 1,683Source NIH's project files

See all 1,683 nih grants

Papers3,553

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Pathway and Mechanism for the Biodegradation of Inosine and Guanosine by Heyndrickxia coagulans NJ01.Foods202642794039PubTator, text miningPubMed
Integrated transcriptomics and metabolomics reveal suppression of the PPAR α/γ pathway linking purine metabolism disorder to high-protein diet-induced hyperuricemia in goslings.Anim Nutr202642741484PubTator, text miningPubMed
Exploring Novel Indazole and Pyrazole Nucleoside Analogues: Enzymatic Synthesis, Characterization, and Biological Evaluation.Int J Mol Sci202642737455PubTator, text miningPubMed
Purine nucleoside phosphorylase in breast cancer from metabolic regulation to targeted therapy: challenges and opportunities.RSC Med Chem202642689267PubTator, text miningPubMed
Mid-life candidate vascular plasma biomarkers are associated with MRI markers of vascular brain injury and amyloid- and tau-PET in cognitively healthy adults.J Alzheimers Dis202642669799PubTator, text miningPubMed
Cadmium-associated cognitive impairment in adults: Proteomics-guided blood-based risk stratification with external validation and rat multimodal corroboration.Environ Pollut202642641860PubTator, text miningPubMed
Extending Chain Length of PNP Pincer Ligands Triggers Catalytic Activity of Gold-Copper Nanoclusters in Aerobic Oxidations.Angew Chem Int Ed Engl202642585034PubTator, text miningPubMed
Repurposing nucleos(t)ide analogs as purine nucleoside phosphorylase inhibitors through Gaussian accelerated molecular dynamics simulations.Biochem Biophys Res Commun202642580172PubTator, text miningPubMed
Proton motive force as a driver of persister sensitization by adenosine.J Biol Chem202642567508PubTator, text miningPubMed
Comprehensive analysis of the association between perfluorooctanoic acid exposure and osteosarcoma progression.Food Chem Toxicol202642462996PubTator, text miningPubMed

1 to 10 of 3,553

See all 3,553 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/4860

GET https://conductscience.org/api/genes/v1/4860/patents?page=2